ZA872523B - Human gamma interferon-specific receptor protein,antibody against said protein,methods for obtaining said protein and said antibody and compositions containing said protein and antibody - Google Patents

Human gamma interferon-specific receptor protein,antibody against said protein,methods for obtaining said protein and said antibody and compositions containing said protein and antibody

Info

Publication number
ZA872523B
ZA872523B ZA872523A ZA872523A ZA872523B ZA 872523 B ZA872523 B ZA 872523B ZA 872523 A ZA872523 A ZA 872523A ZA 872523 A ZA872523 A ZA 872523A ZA 872523 B ZA872523 B ZA 872523B
Authority
ZA
South Africa
Prior art keywords
protein
antibody
obtaining
methods
compositions containing
Prior art date
Application number
ZA872523A
Other languages
English (en)
Inventor
Daniela Novick
Novick Daniela
Patricia Orchansky
Orchansky Patricia
Dina Fischer
Fischer Dina
Menachem Rubinstein
Rubinstein Menachem
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of ZA872523B publication Critical patent/ZA872523B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA872523A 1986-04-08 1987-04-08 Human gamma interferon-specific receptor protein,antibody against said protein,methods for obtaining said protein and said antibody and compositions containing said protein and antibody ZA872523B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL78444A IL78444A (en) 1986-04-08 1986-04-08 Human gamma interferon-specific receptor protein,antibody against said protein,and compositions containing said protein and antibody

Publications (1)

Publication Number Publication Date
ZA872523B true ZA872523B (en) 1987-11-25

Family

ID=11056685

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA872523A ZA872523B (en) 1986-04-08 1987-04-08 Human gamma interferon-specific receptor protein,antibody against said protein,methods for obtaining said protein and said antibody and compositions containing said protein and antibody

Country Status (9)

Country Link
US (1) US4897264A (fr)
EP (1) EP0240975B1 (fr)
JP (2) JPH0787795B2 (fr)
AU (1) AU614487B2 (fr)
CA (1) CA1323728C (fr)
DE (2) DE3750342T2 (fr)
ES (1) ES2061448T3 (fr)
IL (1) IL78444A (fr)
ZA (1) ZA872523B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561649B2 (en) * 1981-02-27 1987-05-14 F. Hoffmann-La Roche Ag Antibodies to proteins
CA1340698C (fr) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation et utilisations de l'interferon gamma
CA1335792C (fr) * 1987-08-18 1995-06-06 Chaim O. Jacob Methode et forme posologique utilisant un antagoniste de l'interferon gamma pour lutter contre les maladies auto-immunes associees au cmh
SE462364B (sv) * 1988-09-30 1990-06-18 Goeran Hansson Anvaendning av gamma-interferon foer beredning av ett preparat foer behandling av vaskulaer stenos
IL88378A (en) * 1988-11-14 2000-11-21 Yeda Res & Dev Human interferon-gamma binding proteins their manufacture and pharmaceutical compositions comprising them
AU625866B2 (en) * 1989-04-19 1992-07-16 F. Hoffmann-La Roche Ag Soluble interferon-gamma receptors and methods for their production
IL91562A0 (en) * 1989-09-07 1990-04-29 Yeda Res & Dev Interferon-gamma receptor fragment and its production
JPH04505019A (ja) * 1989-10-23 1992-09-03 シェリング・コーポレーション ガンマインターフェロンのポリペプチド性阻害剤
DE69104356T2 (de) * 1990-04-24 1995-03-02 Schering Corp Lösliche verkürzte interferon-gamma rezeptoren.
DK0695189T3 (da) * 1992-12-29 1999-08-09 Genentech Inc Behandling af inflammatorisk tarmsygdom med IFN-gammainhibitorer
US20020025316A1 (en) * 1995-08-18 2002-02-28 Ferguson Mark Williams James Pharmaceutical composition containing inhibitors of interferon-gamma
GB2304342A (en) * 1995-08-18 1997-03-19 Univ Manchester Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma
US6589750B2 (en) 1997-02-20 2003-07-08 Institut Pasteur Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives
DE69927520T2 (de) 1998-12-09 2006-06-22 Protein Design Labs, Inc., Fremont Verwendung von il-12 antikörpern zur behandlung von psoriasis
AU2001250412A1 (en) * 2000-03-31 2001-10-08 Ipf Pharmaceuticals Gmbh Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using specific chemokine receptor analysis and the chemokine receptor-ligand interaction
US20040086508A1 (en) * 2001-06-05 2004-05-06 Advanced Biotherapy, Inc. Treatment of organ transplant rejection
US20050152902A1 (en) * 2001-06-05 2005-07-14 Advanced Biotherapy, Inc. Treatment of diabetic retinopathy
WO2004034988A2 (fr) 2002-10-16 2004-04-29 Amgen Inc. Anticorps humains neutralisants anti-ifn-$g(g) utilises comme inhibiteurs selectifs des voies de ifn-$g(g)
AU2004232362C1 (en) * 2003-04-23 2008-05-29 E. R. Squibb & Sons, L.L.C. Compositions and methods for the therapy of inflammatory bowel disease
JP2007525458A (ja) * 2003-04-23 2007-09-06 メダレックス インコーポレイテッド インターフェロンα受容体−１（ＩＦＮＡＲ−１）に対するヒト化抗体
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
WO2005047327A2 (fr) 2003-11-12 2005-05-26 Biogen Idec Ma Inc. Variants de polypeptide se liant au recepteur fc neonatal (fcrn), proteines de liaison fc dimeres et techniques associees
US20050276806A1 (en) * 2004-06-15 2005-12-15 Advanced Biotherapy, Inc. Treatment of autism
US20050276807A1 (en) * 2004-06-15 2005-12-15 Advanced Biotherapy, Inc. Treatment of acne
US7462454B2 (en) * 2004-10-12 2008-12-09 Advanced Biotherapy, Inc. Treatment of herpes
EP1838736B1 (fr) 2005-01-05 2013-03-06 Biogen Idec MA Inc. Molécules à liaison cripto
US7526409B2 (en) * 2005-10-07 2009-04-28 Oracle International Corporation Automatic performance statistical comparison between two periods
EP1957541A2 (fr) 2005-11-21 2008-08-20 Laboratoires Serono SA Compositions et methodes de production de molecules hybrides de fixant a des antigenes, et leurs utilisations
TW201217527A (en) 2010-07-09 2012-05-01 Biogen Idec Hemophilia Inc Processable single chain molecules and polypeptides made using same
WO2013012733A1 (fr) 2011-07-15 2013-01-24 Biogen Idec Ma Inc. Régions fc hétérodimères, molécules de liaison les comprenant, et méthodes associées
US9676849B2 (en) 2012-01-10 2017-06-13 Biogen Ma Inc. Enhancement of transport of therapeutic molecules across the blood brain barrier
CN115181778A (zh) 2015-02-04 2022-10-14 百时美施贵宝公司 选择治疗性分子的方法
AU2024334289A1 (en) 2023-08-25 2026-04-09 Proteologix Us Inc. Anti-il-13 multispecific antibody constructs and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL67896A (en) * 1983-02-13 1987-03-31 Yeda Res & Dev Two biologically active human gama interferon subtypes,purification thereof and pharmaceutical compositions containing them
US4650674A (en) * 1984-07-05 1987-03-17 Genentech, Inc. Synergistic cytotoxic composition
US4751078A (en) * 1985-07-03 1988-06-14 Nagabhushan Tattanahalli L Process for the purification of gamma interferon

Also Published As

Publication number Publication date
JP2577868B2 (ja) 1997-02-05
IL78444A (en) 1992-05-25
CA1323728C (fr) 1993-10-26
JPH0787795B2 (ja) 1995-09-27
JPS6317699A (ja) 1988-01-25
EP0240975B1 (fr) 1994-08-10
JPH0770199A (ja) 1995-03-14
DE240975T1 (de) 1988-02-25
AU7095887A (en) 1987-10-15
EP0240975A2 (fr) 1987-10-14
AU614487B2 (en) 1991-09-05
US4897264A (en) 1990-01-30
ES2061448T3 (es) 1994-12-16
IL78444A0 (en) 1986-08-31
DE3750342D1 (de) 1994-09-15
DE3750342T2 (de) 1994-12-08
EP0240975A3 (en) 1989-09-13

Similar Documents

Publication Publication Date Title
ZA872523B (en) Human gamma interferon-specific receptor protein,antibody against said protein,methods for obtaining said protein and said antibody and compositions containing said protein and antibody
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
EP0260610A3 (en) Monoclonal antibodies against human tumour necrotic factor (tnf), and their use
IL78829A (en) Activator preparation for converting protein c,antithrombotic composition comprising it and method for quantitatively assaying protein c
GB2186592B (en) Cross-protective human monoclonal antibody compositions
EP0240344A3 (en) Monoclonal antibodies and their use
GB8624899D0 (en) Monoclonal antibodies
GB8621910D0 (en) Monoclonal antibodies
EP0203967A4 (fr) Anticorps monoclonaux onco-foetaux specifiques, procedes de preparation et utilisation.
EP0257421A3 (en) Antibodies for use in determining human glycoalbumin
IL77990A (en) Monoclonal anti-alpha-amylase antibody,process for obtaining the same and pharmaceutical compositions containing the same
GB8616174D0 (en) Monoclonal antibodies
IL86710A0 (en) Polypeptide receptor for interleukin-2,antibodies against this polypeptide and pharmaceutical compositions containing the same
IL86960A0 (en) Preparation of human monoclonal antibodies
EP0407586A4 (en) Human monoclonal antibody and process for its preparation
GB8830115D0 (en) Monoclonal antibody and preparation and use thereof
GB2189810B (en) Antibodies their preparation and use and products containing them
EP0344211A4 (fr) Anticorps monoclonaux dans des compositions de vaccins.
ZA876206B (en) Antibodies for use in determining human glycoalbumin
ZA87863B (en) Cross-protective human monoclonal antibody compositions
IL84549A0 (en) Homogeneous sheep t11ts as an intermediate for the preparation of human t11ts,and the use thereof
IL79565A0 (en) Monoclonal antibodies,method for their preparation and use thereof for tumor detection
IE891095L (en) Human monoclonal antibodies
BG42752A1 (en) Alpha substituted gamma lactons and method for their preparation
GB2215725B (en) Monoclonal antibodies